Search Results 661-670 of 16651 for CLL

  1. Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination with Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer - Mayo Clinic

    ... (CLL) in stable remission, or (d) indolent prostate cancer (definition: clinical stage T1 or T2a, Gleason score ≤ 6, and prostate specific antigen [PSA] ...

  2. Publications - Lionel A. Kankeu Fonkoua, M.D. - Mayo Clinic

    Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemia. Mol Ther. 2021 Apr 7; 29 (4):1529-1540 ...

  3. Oncology (Medical) - Doctors - Mayo Clinic

    Tran, M.D.. Mazie Tsang, M.D.. Hematologist / Oncologist. Phoenix, AZ. Areas of focus: Lymphoma, Chronic lymphocytic leukemia, Waldenstrom macroglobulinemia.

  4. Oncology (Medical) - Clinical trials - Mayo Clinic

    Systemic chemotherapy, targeted agents and immunotherapy have largely been ineffective in treatment of LM, in part due to limited CNS/CSF penetration. New ...

  5. Axi-cel treatment for B-cell lymphoma provides real-world outcomes comparable to ZUMA-1 trial data - Mayo Clinic

    In a study of axicabtagene ciloleucel (axi-cel) CAR-T cell therapy for relapsed or refractory aggressive B-cell lymphoma, 30-day responses were comparable ...

  6. A Study to Evaluate Circulating Tumor Cells from Patients with Treatment-Refractory Advanced Solid Tumors Managed in the Early Cancer Therapeutics Program - Mayo Clinic

    The overall objective of this research is to evaluate and define the molecular and biological characteristics of CTCs from advanced solid tumor patients who ...

  7. Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML) - Mayo Clinic

    About this study. Phase I Dose Escalation: To investigate the MTD, safety, efficacy and pharmacokinetics of volasertib in combination with decitabine in ...

  8. A Study of the Safety and Effectiveness of Using Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia - Mayo Clinic

    The purpose of the study is to explore the safety and efficacy of CLT-008 as an extra supportive care measure during induction chemotherapy for patients with ...

  9. In Vivo Assessment of Glutamine Utilization by Bone Marrow Plasma Cells - Mayo Clinic

    This study will establish in vivo and ex vivo methodologies of assessing the utilization of extracellular nutrients by normal bone marrow plasma cells from ...

  10. Clinical trials - Oncology (Medical)

    The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric cancer patients ...